Skip to main content
. Author manuscript; available in PMC: 2022 Sep 12.
Published in final edited form as: ALTEX. 2022 Mar 1;39(3):499–518. doi: 10.14573/altex.2202141

Fig. 5: The use of NAM in AOP-based chemical risk assessment.

Fig. 5:

AO, adverse outcome; TKTD, toxicokinetic-toxicodynamic; IVIVE, in vitro to in vivo extrapolation; grey triangle, (increasing) exposure leading to a response; black dot, NAM-evidence supported response; ?, indicator of the uncertainty related to extrapolating the NAM-evidence supported response to an AO